Geoff Green has been with Longeveron since early 2016, previously as the Senior Vice President of Clinical Operations. As President of Longeveron, he leads the company’s strategic and clinical research initiatives globally. His professional background spans clinical drug development and operations, regulatory affairs, business development, and corporate development and operations. Previously, Green held positions at Accu-Break Pharmaceuticals, DOR BioPharma, Heart Genomics, Innovative Drug Delivery Systems, PolaRx Biopharmaceuticals, Paramount Capital and Partikula. Green earned a Bachelor of Arts in biology from Kenyon College and a Master of Business Administration from Barry University’s Andreas School of Business.